Introduction
Voltage-dependent Ca 2ϩ channels perform an astonishing array of specialized functions in neurons. In perisomatic and dendritic regions, L-type Ca 2ϩ channels are particularly important in translating synaptic activity into alterations in gene expression and neuronal function. Synaptically driven activation of transcription factors, like cAMP response element-binding protein (CREB) and nuclear factor of activated T-cells, depend on these channels (Murphy et al., 1991; Bading et al., 1993; Graef et al., 1999; Mermelstein et al., 2000; Dolmetsch et al., 2001 ). L-type Ca 2ϩ channels also are key participants in the regulation of longterm alterations in synaptic strength (Bolshakov and Siegelbaum, 1994; Calabresi et al., 1994; Kapur et al., 1998; Yasuda et al., 2003) as well as short-term dendritic excitability, the active processing of synaptic events and repetitive spiking (Avery and Johnston, 1996; Hernandez-Lopez et al., 2000; Bowden et al., 2001; Lo and Erzurumlu, 2002; Vergara et al., 2003) .
The engagement of L-type Ca 2ϩ channels is regulated by G-protein-coupled receptors (GPCRs). In a variety of excitable cells, GPCRs modulate L-type channel opening by controlling channel phosphorylation state (Hell et al., 1993a; Surmeier et al., 1995; Gao et al., 1997; Kamp and Hell, 2000) . In striatal medium spiny neurons, both D 2 dopaminergic and M 1 muscarinic receptors suppress L-type Ca 2ϩ channel currents by activating the Ca 2ϩ /calmodulin-dependent protein phosphatase calcineurin (Howe and Surmeier, 1995; Hernandez-Lopez et al., 2000) . However, it isn't clear whether GPCRs modulate perisynaptic L-type Ca 2ϩ channels. Both GPCRs are found in abundance near corticostriatal glutamatergic synapses that are formed preferentially on spine heads in medium spiny neurons (Bolam et al., 2000) , where functional studies suggest L-type channels are located (Calabresi et al., 1994; Cepeda et al., 1998) .
The physical association that would be necessary for synaptic GPCR regulation of L-type channels could be created by synaptic scaffolding or adaptor proteins (Kennedy, 1998; Sheng and Kim, 2000) . Recent work has shown that L-type Ca 2ϩ channels possessing a pore-forming Ca V 1.2 subunit bind to several adaptor proteins, and this interaction enables phosphorylated pCREB signaling (Kurschner et al., 1998; Kurschner and Yuzaki, 1999; Weick et al., 2003) . This terminal region also associates the channel with signaling enzymes and GPCRs (Davare et al., 2000 (Davare et al., , 2001 . Much less is known about targeting of the other major class of L-type Ca 2ϩ channel found in neurons in which the pore is formed by a Ca V 1.3 subunit. Unlike Ca V 1.2 channels, these channels open at membrane potentials likely to be achieved during modest synaptic stimulation (Koschak et al., 2001; Scholze et al., 2001; Xu and Lipscombe, 2001 ). The C-terminal region of this subunit is alternatively spliced, yielding long (Ca V 1.3a) and short (Ca V 1.3b) variants (Safa et al., 2001; Xu and Lipscombe, 2001 ). The long splice variant contains an Src homology 3 (SH3) and a class I PDZ (postsynaptic density-95 (PSD-95)/Discs large/zona occludens-1) binding domain that selectively binds Shank proteins, which are thought to be key scaffolding elements in the synaptic signaling complex (Kennedy, 1998; Sheng and Kim, 2000) . The results presented here suggest that, indeed, Shank targeting of Ca V 1.3a channels enables their selective modulation by dopaminergic and cholinergic GPCRs.
Materials and Methods
Animals. C57BL/6 mice were obtained from Harlan (Indianapolis, IN). Ca V 1.3 knock-out mice were obtained from Joerg Striessnig (Institut für Biochemische Pharmakologie, Innsbruck, Austria) (Platzer et al., 2000) , rederived, and backcrossed on a C57Bl/6 background in the Northwestern University barrier facility. All experiments followed protocols approved by the Northwestern University Center for Comparative Medicine, an Association for Assessment and Accreditation of Laboratory Animal Care accredited facility, and followed guidelines issued by the National Institutes of Health and the Society for Neuroscience.
Tissue preparation for single neurons. The brain was removed from young (Ͼ3-6 weeks of age) male C57BL/6 mice, chilled, sliced (300 m) coronally in sucrose, and immediately placed in NaHCO 3 -buffered Earl's balanced salt solution saturated with 95% O 2 and 5% CO 2 where it was held from 20 min to 6 h. The striatum was dissected from the slices immediately before dissociation and placed in HBSS saturated with O 2 and containing type XIV bacterial protease (1 mg/ml) for 25 min. EDTA (0.5 mM) and L-cysteine (1 mM) was added to papain (final concentration, 40 U/ml, pH 7.2) (Raman et al., 2000) for experiments involving D 2 , M 1 , or 5-HT 2 receptor agonists. Penicillin-streptomycin was added to the papain solution to inhibit bacterial growth. After enzyme digestion, the tissue was triturated for physical dissociation of the medium spiny neurons and then placed in a suspension dish. In some experiments, Ca V 1.3 (Platzer et al., 2000) or Ca V 2.3 (Wilson et al., 2000) knock-out mice were used for experiments.
Whole-cell voltage-clamp recordings in acutely isolated neurons. Wholecell recordings used standard techniques (Bargas et al., 1994) . The internal solution contained the following (in mM): 180 N-methyl-Dglucamine, 40 HEPES, 4 MgCl 2 , 12 phosphocreatine, 2 Na 2 ATP, 0.5 Na 3 GTP, and 0.1 leupeptin, pH 7.2-3, with H 2 SO 4 , 265-270 mOsm/L. A calcium chelator was often omitted; however, for the experiments with dialysis of Ca V 1.2 binding peptide into the cell, EGTA (100 M) was added to the internal. A 2-5 mM Ba 2ϩ NaCl external recording solution was used (in mM: 110 NaCl, 1 MgCl 2 , 2-5 BaCl 2 , 10 HEPES, 10 glucose, pH 7.35-7.4, 300 mOsm/L). In experiments determining dihydropyridine affinity or voltage dependence of activation, the major salt was tetraethyl-ammonium chloride (135 mM). All drugs were prepared according to the specifications of the manufacturers and applied with a gravity-fed "sewer pipe" capillary array . Electrodes were pulled and fire-polished to 1-2 m for sufficient resistance in the bath (2-6 M⍀). For acutely isolated recordings, medium spiny neuron morphological identification was supported by a whole-cell capacitance ranging from 2-10 pF. Isolation of calcium currents was possible with the use of tetrodotoxin (TTX; 200 M) to block sodium currents and CsCl (20 mM) to block potassium currents. All reagents were obtained from Sigma (St. Louis, MO) except GTP (Roche Diagnostic, Indianapolis, IN), TTX (Alomone Labs, Jerusalem, Israel), leupeptin, -conotoxin GVIA (Bachem, Torrance, CA), papain (Worthington, Lakewood, NJ), penicillin-streptomycin (Invitrogen, Carlsbad, CA), and -agatoxin TK (Peptides International, Louisville, KY). Ca V 1.2 COOH-tail and Ca V 1.3 Shank-PDZ binding peptides were synthesized by Biosource (Hopkinton, MA). Ca V 1.2 COOH-tail peptide sequence was SEEALPD-SRSYVSNL, and Ca V 1.3 Shank-PDZ binding peptide sequence was EE-EDLADEMICITTL. Whole-cell voltage-clamp recordings were obtained with an Axon Instruments (Foster City, CA) 200A patch-clamp amplifier and controlled and monitored with a Macintosh G4 running pulse 8.53 with a 125 KHz interface. Data were analyzed using Igor Pro 4.05, and Systat 5.2 and SigmaStat 3.0 software were used for statistical analysis. For clarity, the capacitance artifacts were suppressed in the figures containing current traces. Box plots were used to represent small sample sizes.
Whole-cell recordings in slices. Slices were obtained as described above and placed for Ͼ1 h into an artificial CSF (ACSF) containing the following (in mM): 125 NaCl, 3.5 KCl, 25 NaHCO 3 , 1.25 Na 2 HPO 4 , 1 MgCl 2 , 1.2 CaCl 2 , 25 glucose, pH 7.3, with NaOH, 300 mOsm/L, saturated with 95% CO 2 and 5% O 2 . Thereafter, slices were transferred to a recording chamber and superfused with ACSF at a rate of 3-4 ml/min. Currentclamp recordings were performed on visually identified medium spiny neurons with an infrared video-microscopy system. The pipette solution consisted of the following (in mM): 119 KMeSO 4 , 1 MgCl 2 , 0.1 CaCl 2 , 10 HEPES, 1 EGTA, 12 phosphocreatine, 2 Na 2 ATP, 0.7 Na 2 GTP, pH 7.2-3, with KOH, 280 -300 mOsm/L. Whole-cell recordings were obtained at 32°C.
Single-cell reverse transcription-PCR. Two types of reverse transcription (RT)-PCR profiling were performed. To maximize mRNA yields, some neurons were aspirated without recording. Isolated neurons were patched in the cell-attached mode and lifted into a stream of control solution. Neurons were then aspirated into an electrode containing sterile water. In other experiments, neurons were briefly subjected to recordings before aspiration. In these cases, the electrode recording solution was made nominally RNase free. RT procedure was performed using Superscript First-Strand Synthesis System (Invitrogen) as described previously (Surmeier et al., 1996) . Primers for enkephalin (ENK) and upper primer for substance P (SP) were described previously (Surmeier et al., 1996) . The lower primer for SP was ATG AAA GCA GAA CCA GGG GTA G (position 838; GenBank accession number D17584), which gave a PCR product of 616 bp. Ca V 1.2 mRNA (GenBank accession number NM009781) was detected with a pair of primers GAC AAC TGA CCT GCC CAG AG (position 6763) and GCT GTT GAG TTT CTC GCT GGA (position 7098), which gave a PCR product of 356 bp. Ca V 1.3 mRNA (GenBank accession number AJ437291) was detected with a pair of primers CTG ACT CGG GAC TGG TCT ATT C (position 4363) and CTG GAG GGA CAA CTT GGT CAA GCA (position 4718), which gave a PCR product of 379 bp. For detection of Ca V 1.3 splice variant mRNAs, a common upper primer TCC GGA CAG CTC TCA AGA TCA AG (position 4616) was used. The lower primer for the long form of Ca V 1.3 was GAC GGT GGG TGG TAT TGG TCT GC (position 5058), which gave a PCR product of 465 bp. The lower primer for the short form of Ca V 1.3 was GCG GTA GCT CAG GCA GAC AAC TC (position 4932; GenBank accession number AF370009), which gave a PCR product of 306 bp. TH mRNA (GenBank accession number NM012740) was detected with a pair of primers CAG GAC ATT GGA CTT GCA TCT (position 1415) and ATA GTT CCT GAG CTT GTC CTT G (position 1690), which gave a PCR product of 297 bp.
Immunoprecipitation. Rat brain synaptosomal fraction [postnatal day 2 (P2)] was purified as described previously (Maximov et al., 1999) and solubilized in the extraction buffer B containing 1% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate as follows (in mM): 137 NaCl, 2.7 KCl, 4.3 Na 2 HPO 4 , 1.4 KH 2 PO 4 , 5 EDTA, 5 EGTA, and protease inhibitors, pH 7.2. The lysate was clarified by cen-trifugation at 100,000 ϫ g and incubated for 2 h at 4°C with protein A-Sepharose beads (Amersham Biosciences, Piscataway, NJ) coated with affinity-purified anti-Ca V 1.3a polyclonal antibody (pAb). Beads were pelleted by centrifugation, washed two times in the extraction buffer, and analyzed by Western blotting with guinea pig anti-Shank pAb.
Immunocytochemistry. Rabbit anti-Shank was a generous gift from Dr. Eunjoon Kim (Korea Advanced Institute of Science and Technology, Daejeon, Korea); mouse monoclonal anti-PSD-95 (clone 7E3-IB8) was purchased from Sigma-Aldrich; Alexa Fluor 488-and 568-labeled antirabbit and anti-mouse goat IgGs were from Molecular Probes (Eugene, OR). Eight normal C57BL/6 male mice and two Ca V 1.3 knock-out mice were deeply anesthetized with sodium pentobarbital (60 mg/kg body weight, i.p.) and transcardially perfused with 0.9% saline, followed by 4% freshly depolymerized paraformaldehyde and 15% saturated picric acid in 0.1 M phosphate buffer (PB), pH 7.4, at 4°C. Brains were dissected out, postfixed at room temperature for 1 h, and cryoprotected in 30% sucrose in PB. Frozen sections were cut in the sagittal and coronal planes at 20 m on a freezing stage microtome. Free-floating sections were processed for indirect immunofluorescence. Unspecific binding was suppressed in a blocking solution containing 5% normal goat serum (NGS) in PBS with 0.05% Triton X-100 for 1 h at room temperature. Sections were then incubated with primary antibodies diluted in 2% NGS/PBS-0.05 Triton X-100 overnight at 4°C, followed by incubation with fluorescent secondary antibodies for 30 min at room temperature. After rinsing in PBS, sections were mounted with Vectashield (Vector Laboratories, Burlingame, CA). For double labeling, sections were incubated with pairs of primary antibodies (anti-PSD-95/anti-Shank, or anti-PSD-95/antiCa V 1.3a) and then with pairs of appropriate IgGs tagged with Alexa Fluor 488 and 568. Control sections incubated with normal serum in lieu of the primary antiserum were free of immunolabeling, and Ca V 1.3a knock-out mice did not show any immunoreactivity after incubation with antiserum to Ca V 1.3a.
Dissociated striatal neurons were obtained as described above, collected on a polylysine-coated glass slide, and fixed with 4% freshly depolymerized paraformaldehyde in 0.1 M PB, pH 7.4, at 4°C. Slides were immunoreacted as above with rabbit anti-Ca V 1.3a and rabbit antiShank, and binding sites were revealed with Alexa Fluor 488 and 568-labeled rabbit and goat IgGs. After coverslipping with Vectashield, slides were analyzed by fluorescence microscopy.
Laser-scanning confocal immunofluorescence microscopy was done on a Nikon Eclipse 800 microscope equipped with a Nikon PCM 2000 Confocal Microscope System (Nikon, Melville, NY). This utilizes an Argon laser (457, 488, 514 nm) and a green HeNe laser (535.5 nm). Standard emission filter 515/530 and bandpass filter 605/632 transmitting light between 589 and 621 nm were used for Argon and HeNe lasers, respectively. The system allowed simultaneous detection as well as sequential detection of orange/red (TCP-1 ring complex; Alexa 568; Texas Red) and green (FITC; Alexa 488; and green fluorescent protein) dyes. Detection parameters for sequential detection were optimized for each dye, and spillover between channels was minimized. Images for analysis were obtained with a Nikon planapochromatic 60ϫ (numerical aperture, 1.4) oil immersion lens. Sequential optical sections were taken at 0.5-2.0 m intervals in the Z plane to build an image volume in three dimensions on a graphics workstation using commercial software (SIM-PLE PCI program; Compix Imaging Systems, Lake Oswego, OR). Software settings for optimal gain and black levels were individually adjusted for each fluoroprobe.
Spatial cross-correlations were computed from aligned, 0.5 m thick, optical sections. The goal of this analysis was to determine whether there was a consistent spatial relationship between immunofluorescent signal intensity for Ca V 1.3, PSD-95, and Shank. Although our analytic approach differed somewhat from that recently described by Li et al. (2004) , the approach was conceptually similar. Paired neuropil images for PSD-95/Shank or PSD-95/Ca V 1.3a were imported to Adobe Photoshop (Adobe Systems, San Jose, CA). Here, images were converted from color to grayscale; the files were not manipulated in any other way (e.g., no deconvolution or smoothing). Image intensity files were then imported as two-dimensional matrices into Igor Pro where they were standardized using self-reference. Conventional, spatial cross-correlations between aligned, standardized image matrices (Bendat and Piersol, 1971) were computed on a row pixel by row pixel basis for pixel lags up to the equivalent of 10 m (column-by-column approach yielded similar results). The two-dimensional cross-correlation was then collapsed by averaging across columns. To obtain a measure of the correlation expected by chance, image rows and columns were shifted four times by a random number (generated from a uniform distribution by Igor Pro) and then the image cross-correlations were recomputed. This is presented as the "shuffled" correlation. This shuffling consistently led to "flat" crosscorrelations and gave a measure of the background signal generated by the algorithm.
Results

D 2 dopaminergic and M 1 muscarinic receptors suppress Ltype Ca
2؉ channel currents in striatal medium spiny neurons The vast majority of neurons in the rodent striatum are GABAergic medium spiny neurons (Ͼ90%). They can readily be identified by their typically bipolar shape and medium size (see Fig.  2 A) . Virtually all medium spiny neurons express M 1 and M 4 muscarinic receptors, reflecting the prominent role of cholinergic signaling in the functioning of the striatum (Graybiel, 1984; Bernard et al., 1992; Yan et al., 2001 ). Another key neuromodulator in the striatum is dopamine. The postsynaptic effects of dopamine are mediated mostly by D 1 and D 2 dopaminergic receptors, which are differentially expressed by medium spiny neurons projecting to the substantia nigra and the globus pallidus, respectively (Albin et al., 1989; Gerfen, 1992; Surmeier et al., 1996) .
One of the most prominent consequences of D 2 dopaminergic or M 1 muscarinic receptor activation in medium spiny neurons is the suppression of L-type Ca 2ϩ channel currents. This is easily seen in whole-cell recordings from acutely isolated medium spiny neurons in the presence of the dihydropyridine agonist S(Ϫ)-BayK 8644 (1 M). BayK 8644 enhances the open probability of L-type channels and slows their deactivation rate, enabling them to be examined in isolation without using blockers for the other Ca 2ϩ channels. The slowing of the deactivation kinetics can be seen clearly in Figure 1A . In the presence of BayK 8644, the application of the D 2 receptor agonist R(Ϫ)-propyl-norapomorphine hydrochloride (NPA; 10 M) reversibly reduces the amplitude of slow, L-type tail currents in approximately half of all medium spiny neurons (Fig.  1A ,B) (Hernandez-Lopez et al., 2000) . The tail currents are shown at higher resolution in the right panel in Figure 1A . Typically, NPA reduced tail currents measured 5 ms after the repolarizing step by ϳ20%. Similarly, application of the muscarinic receptor agonist muscarine (2 M) reversibly reduced the slow tail currents resulting from L-type channels in medium spiny neurons (Fig. 1C,D) . Both GPCRs bring about their modulation by turning on phospholipase C␤ (PLC␤) isoforms, mobilizing inositol trisphosphate (IP 3 ) receptor (IP 3 R) Ca 2ϩ stores and activating the calcium-dependent protein phosphatase calcineurin (Howe and Surmeier, 1995; Hernandez-Lopez et al., 2000) .
Medium spiny neurons coexpress Ca V 1.2 and Ca V 1.3 mRNAs Although D 2 and M 1 receptor activation suppresses L-type Ca 2ϩ channel currents, it is not known whether this modulation is specific to a particular channel subtype. In the brain, L-type channels have either a Ca V 1.2 or Ca V 1.3 pore-forming subunit (Catterall, 1998) . To determine whether one or both of these was expressed in striatal medium spiny neurons, single-cell RT-PCR (scRT-PCR) profiling was performed. Medium spiny neurons were identified by their expression of SP or ENK mRNAs. These two peptides reliably mark the two major populations of medium spiny neurons that form so-called "direct" and "indirect" path-ways (Gerfen, 1992) . These two populations also differ in their expression of D 1 and D 2 receptors. Because the mRNAs for these peptides have high single-cell copy numbers, they are much more reliable markers in scRT-PCR protocols than low abundance GPCR mRNAs that can easily be missed (Surmeier et al., 1996) . These experiments revealed that both SP and ENK neurons coexpressed Ca V 1.2 and Ca V 1.3 ␣ subunit mRNAs (Fig. 2 B) . Ca V 1.2 and Ca V 1.3 mRNA were found in Ͼ70% of a large sample of medium spiny neurons (n ϭ 53) (Fig. 2C) . Given the probability of false negatives with low-abundance templates at the single-cell level, these results suggest that virtually all medium spiny neurons coexpress Ca V 1.2 and Ca V 1.3 mRNAs.
Ca V 1.2 and Ca V 1.3 channels in medium spiny neurons differ pharmacologically and biophysically In heterologous expression systems, Ca V 1.2 and Ca V 1.3 channels differ in their affinity for dihydropyridine antagonists (Koschak et al., 2001; Xu and Lipscombe, 2001) . To determine whether this distinction was maintained in a native expression system, medium spiny neurons were acutely isolated, voltage clamped using whole-cell techniques, and Ca 2ϩ channels were pharmacologically isolated (Bargas et al., 1994) . Using Ba 2ϩ (5 mM) as a charge carrier to eliminate Ca 2ϩ -dependent inactivation, fast (150 ms) voltage ramps running from Ϫ80 to ϩ30 mV from a holding potential of Ϫ60 mV were used to activate channels (Fig. 3A) . To better isolate L-type channel currents, Ca V 2.1/2.2 channels were blocked (using a combination of -conotoxin GVIA and -agatoxin TK), leaving just Ca V 1 (L-type) and Ca V 2.3 (R-type) channels capable of fluxing ions (Bargas et al., 1994) . In this situation, the application of the Ca V 1, L-type channel antagonist nimodipine blocked the evoked current in a dose-dependent manner. Selected traces from one of these experiments are shown in Figure 3A . Construction of dose-response plots from wild-type neurons were well fit only with two-site Langmuir isotherm having IC 50 values near 200 nM and 2 M (n ϭ 8) (data not shown), values close to those obtained for Ca V 1.2 and Ca V 1.3 channels, respectively, in heterologous expression systems (Koschak et al., 2001; Xu and Lipscombe, 2001) . At 10 M, nimodipine blocked Ͼ90% of the current (Fig. 3A) with little increase in the block until concentrations reached 50 M, at which point Ca V 2.3 channels began to be blocked (P. A. Olson, R. J. Miller, and D. J. Surmeier, unpublished observations). The low-affinity binding site was preserved in medium spiny neurons from Ca V 2.3 knock-out mice (Wilson et al., 2000) (n ϭ 8), arguing that there was no confusion with this R-type Ca 2ϩ channel. To verify that the high affinity site was attributable to Ca V 1.2 channels, medium spiny neurons from Ca V 1.3 knock-out mice were examined. As predicted, L-type currents in these neurons were completely blocked by 1 M nimodipine (Fig. 3B) (n ϭ 8) . These data show that medium spiny neurons coexpress Ca V 1.2 and Ca V 1.3 Ca 2ϩ channels that can be separated primarily on the basis of their sensitivity to dihydropyridine antagonists. In addition, we studied the voltage dependence of the dihydropyridine block (Bean, 1984) . Ca V 1.2 sensitivity was not affected by holding potential. In contrast, holding the membrane potential at Ϫ80 mV dramatically reduced Ca V 1.3 channel block by nimodipine, shifting the IC 50 value by a factor of ϳ10 (Xu and Lipscombe, 2001) .
This difference in nimodipine sensitivity was then used to determine whether Ca V 1.2 and Ca V 1.3 channels were biophysically distinguishable. To determine the voltage dependence of Ca V 1.2 channels, the currents that were resistant to blockade by 200 nM nimodipine were subtracted from control currents. This should yield currents that were solely attributable to Ca V 1.2 channels. Ca V 1.2 channel current-voltage plots derived from wild-type neurons peaked near 0 mV (Fig. 3C, black trace) ; currents isolated from Ca V 1.3 knock-out neurons were virtually identical (Fig. 3C, gray trace) . Ca V 1.3 channel currents were operationally defined as those blocked by 10 M but not 1 M nimodipine. In contrast to Ca V 1.2 channels, these channels activated at relatively hyperpolarized membrane potentials (Fig. 3D) . Permeability estimates were calculated to give a better picture of how channel open probability changed with voltage (Bargas et al., 1994) . These estimates were readily fit with a single-site Boltzmann function (Fig. 3E) . Based on this analysis, the halfactivation voltage of Ca V 1.3 channels was ϳ15 mV more negative than that for Ca V 1.2 channels. The data from these experiments are summarized in a nonparametric format in Figure 3F . Ca V 1.2 channel currents had half-activation voltages of approximately Ϫ5 mV in wild-type neurons as well as in neurons from Ca V 1.3 and Ca V 2.3 knock-outs. In contrast, Ca V 1.3 channel currents had half-activation voltages between Ϫ20 and Ϫ25 mV in neurons from wild-type and Ca V 2.3 knock-out mice, significantly more negative than Ca V 1.2 channels (n ϭ 5; p Ͻ 0.05, Mann-Whitney). These results show that medium spiny neurons coexpress functional Ca V 1.2 and Ca V 1.3 L-type channels and that these channels differ in both their dihydropyridine and voltage sensitivity. We next asked whether these two channels were differentially modulated by GPCRs. D 2 dopaminergic and M 1 muscarinic receptors selectively modulate Ca V 1.3 channels To determine whether Ca V 1.2 or Ca V 1.3 channels were targeted by D 2 receptor activation, recordings were made from medium spiny neurons in which the Ca V 1.3 subunit had been genetically deleted (Platzer et al., 2000) . To our surprise, D 2 receptor agonists had no effect on tail currents in these neurons (Fig. 4 A) . This was not a consequence of D 2 receptor dysfunction, because the modulation of Ca V 2.1/2.2 channel currents evoked by the step depolarization, which relies on a distinct, membranedelimited signaling cascade, remained. To verify that recordings were made from the subset of neurons expressing D 2 receptors, scRT-PCR profiling was performed. In a sample of six Ca V 1.3-deficient neurons expressing ENK mRNA, a reliable marker of D 2 receptor-expressing neurons (Gerfen, 1992; Surmeier et al., 1996) , none exhibited a discernible reduction in tail amplitude after NPA application (Fig. 4C,D) . In contrast, the modulation of the Ca V 2.1/2.2 (N, P/Q) currents evoked by the depolarizing step was not significantly altered (n ϭ 4; median suppression control, 16%; Ca V 1.3 knock-out, 20%; p Ͼ 0.05, Kruskal-Wallis) (Hernandez-Lopez et al., 2000) . To provide an additional test of the D 2 receptor selectivity, ramp currents in wild-type neurons were examined. Again, concentrations of nimodipine (1 M) that fully block Ca V 1.2 channels failed to significantly reduce the effects of NPA, whereas concentrations of nimodipine (10 M) that (5 mM) as the charge carrier. Currents were elicited by a voltage protocol of Ϫ80 mV ramp to ϩ30 mV (150 ms); the holding potential was Ϫ60 mV. B, Ca 2ϩ channel currents in Ca V 1.3 knock-out medium spiny neurons show only the high-affinity block by nimodipine (1 M; n ϭ 8). Recording conditions were the same as for A. C, Currents blocked by 200 nM nimodipine from wild-type (black) and Ca V 1.3 knock-out neurons (gray) have similar voltage dependence. Conditions were as in A and B. D, Low-affinity channels (blocked by the increment from 1 to 10 M nimodipine) in wild-type neurons (black) activated at more negative membrane potentials than currents blocked by 200 nM nimodipine (gray). E, Permeability estimates derived from the currents blocked by low (200 nM) and high (1-10 M) nimodipine. Permeability estimates were fit with first-order Boltzmann functions: high-affinity Ca V 1.2, V h ϭ Ϫ9 mV; low-affinity Ca V 1.3, V h ϭ Ϫ19 mV. F, Statistical summary of half-activation voltages for high-affinity Ca V 1.2 currents (left) and low-affinity Ca V 1.3 currents (right). Ca V 1.2 currents blocked by 200 nM nimodipine: wild-type median, V h ϭ Ϫ5 mV (n ϭ 3); Ca V 1.3 knock-out median, V h ϭ Ϫ10 mV (n ϭ 9); Ca V 2.3 knock-out median, V h ϭ Ϫ9 mV (n ϭ 5). Currents blocked by 10 M but not 1 M nimodipine: wild-type median, V h ϭ Ϫ22 mV (n ϭ 6); Ca V 2.3 knock-out median, V h ϭ Ϫ32 mV (n ϭ 4). also blocked Ca V 1.3 channels occluded the modulation, leaving the residual Ca V 2.1/2.2 channel current modulation (n ϭ 4) (Fig.  4 B) .
Next, the selectivity of M 1 muscarinic receptor linkage was examined. As with the D 2 receptor modulation, the effect of muscarine on the slow, L-type tail currents was abolished in neurons lacking Ca V 1.3 channels (Fig. 4C) . This result suggests that activation of the ubiquitously expressed M 1 receptor, which is responsible for the suppression of L-type channel currents, selectively targets Ca V 1.3 channels. Despite the loss of this modulation, the M 4 muscarinic receptor suppression of Ca V 2.1/ 2.2 Ca 2ϩ channels (Howe and Surmeier, 1995; Yan et al., 2001 ) was left intact in the Ca V 1.3-deficient neurons. This can be seen in the response to the step depolarization (n ϭ 5; median suppression control, 19%; Ca V 1.3 knock-outs, 17%; p Ͼ 0.05, KruskalWallis). To provide another test of the selectivity of the M 1 receptor modulation, ramp currents were recorded in wild-type neurons as described above. Concentrations of nimodipine (1 M) that should fully block Ca V 1.2 channels failed to substantially alter the magnitude of the muscarinic modulation, whereas application of Ca V 1.3-inclusive concentrations of nimodipine (10 M) occluded the effects of muscarine (Fig. 4 D) (n ϭ 5), leaving the residual M 4 modulation of Ca V 2.1/2.2 channels. Last, the voltage dependence of the current modulated by muscarine was estimated by subtracting the currents unaffected by muscarine from control currents. This analysis yielded currents with a halfactivation voltage indistinguishable from that of Ca V 1.3 channels isolated pharmacologically (n ϭ 6) (data not shown) (see supplemental figure, available at www.jneurosci.org as supplemental material). Zhang et al. (2005) have shown that the scaffolding protein Shank selectively interacts with SH3 and PDZ binding domains in the C-terminal region of a long Ca V 1.3 splice variant (Ca V 1.3a). An interaction with Shank could bring Ca V 1.3 channels into physical proximity to D 2 /M 1 receptors and elements of the signaling cascade they engage (Sheng and Kim, 2000) . As a first step toward testing this hypothesis, whole striatal tissue was profiled for the presence of the two C-terminal splice variants of Ca V 1.3 expressed in the brain (Safa et al., 2001 ). Serial dilution RT-PCR revealed that both long (Ca V 1.3a) and short (Ca V 1.3b) variants were present but that Ca V 1.3a was present at apparently higher levels (Fig. 5A) . Profiling of individual medium spiny neurons confirmed this analysis, showing that Ca V 1.3a mRNA was easily detected in both ENK-and SPexpressing subtypes of medium spiny neurons (14/15) (Fig. 5B) . In contrast, Ca V 1.3b was infrequently detected (2/15). This was not a limitation posed by the single-cell analysis, because Ca V 1.3b was readily detected in dopaminergic neurons of the substantia nigra (n ϭ 5) (Fig. 5B, right panel) .
Medium spiny neurons coexpress a long Ca V 1.3 channel splice variant and interacting Shank isoforms
The C-terminal region of Ca V 1.3a subunits binds preferentially with two of the three Shank isoforms found in the brain (Shank3/Shank1) (Zhang et al., 2005) . If targeting of Ca V 1.3 channels was dependent on Shank in medium spiny neurons, they should express one or both of these isoforms. To determine whether this was the case, striatal tissue was assayed for Shank mRNA. At the tissue level, all three Shank isoforms were readily detected at nominally the same level of abundance (Fig. 5C ). However, in medium spiny neurons, the Shank isoform with the highest affinity for the Ca V 1.3a subunit, Shank3, appeared to be the most abundant, being detected in seven of eight cells. Shank1, which also has a high affinity for the Ca V 1.3a terminal region, also Figure 1 . NPA had no effect on the L-type tail current. The inset shows scRT-PCR confirmation that the neuron expressed enkephalin, a marker for D 2 receptor expression. B, Box plot illustrates the difference in percentage inhibition of L-type tail currents by D 2 receptor activation in medium spiny neurons from wild-type (n ϭ 3; median, 18%) and Ca V 1.3 knock-out (n ϭ 6; median, 0%) mice ( p Ͻ 0.05; Mann-Whitney). Also shown is the box plot summary of experiments examining the reduction in peak ramp current by NPA (10 M) after the addition of low (low nim; 1 M; n ϭ 4) and high (high nim; 10 M; n ϭ 4) nimodipine. The amplitude of the modulation in low and high nimodipine divided by the control modulation is plotted; values close to 100 indicate no effect on the modulation, whereas values close to 0 indicate occlusion. C, Current traces from a dorsal striatal medium spiny neuron from a Ca V 1.3 knock-out mouse. Experimental conditions were the same as Figure 1 . Muscarine had no effect on the L-type tail current. D, Box plot illustrates the difference in percentage inhibition of L-type tail currents by M 1 receptor activation in medium spiny neurons from wild-type (n ϭ 5; median, 20%) and Ca V 1.3 knock-out (n ϭ 5; median, 0%) mice ( p Ͻ 0.05; Mann-Whitney). Also shown is the box plot summary of experiments examining the reduction in peak ramp current by muscarine (10 M) after the addition of low (low nim; 1 M; n ϭ 5) and high (high nim; 10 M; n ϭ 5) nimodipine. The amplitude of the modulation in low and high nimodipine divided by the control modulation is plotted; values close to 100 indicate no effect on the modulation, whereas values close to 0 indicate occlusion.
was readily detected (5/8), whereas Shank2 was not detected at all (0/8) (Fig. 5D) . This pattern was cell-type specific, because examination of cholinergic interneurons failed to detect Shank2 or Shank3 but readily detected Shank1 (Fig. 5E) (n ϭ 6) .
Next, to determine whether Ca V 1.3a channels and Shank were in close physical proximity, striatal tissue sections were studied using immunocytochemical approaches. Because both Ca V 1.3a and Shank antibodies were raised in the same host, colabeling of the same section was not possible. Because PSD-95 is colocalized with Shank at excitatory synapses (Sheng and Kim, 2000) , it was used as a surrogate marker. As expected, PSD-95 immunoreactivity in striatal tissue had a punctate distribution (Fig. 6 A, top left) , reflecting the localization of excitatory synapses predominantly on dendritic spine heads (Kennedy, 1998; Bolam et al., 2000) . Shank immunoreactivity was punctate as well but had an additional somatic component that presumably reflected cytoplasmic protein (Fig. 6 A, top center) . Color overlays from 500 nm optical sections provided evidence that these two proteins had a significant level of colocalization (Fig. 6 A, top right) . However, the images were not perfectly aligned, as one might expect if the proteins were slightly displaced from one another near synapses. To quantify the relationship, spatial crosscorrelations were computed on aligned image fields after standardizing the optical image intensity (Li et al., 2004) . To reduce spurious correlations attributable to somatic labeling, fields in which there were few visible somata were chosen for analysis. This analysis consistently revealed a strong spatial correlation between PSD-95 and Shank labeling that was strongest with no image displacement and then sharply declined within ϳ1 m, approximately the dimension of a spine (Fig. 6 B) . In a sample of five sections, the median peak cross-correlation was 0.35 (range, 0.71-0.23). The secondary slower decline in the cross-correlation in Figure 6 B reflected somatic labeling, because it was absent in correlations from subfields lacking any obvious somatic profiles.
Ca V 1.3a immunolabeling was strikingly similar to that for PSD-95, being distinctly punctate (Fig. 6 A, bottom center) . Overlays of regions processed for both PSD-95 and Ca V 1.3a revealed a significant degree of colocalization (Fig. 6 A, bottom  right) . To quantify the relationship between the two markers, cross-correlation analysis was performed as for Shank and PSD-95. Analysis of five different sections consistently found a strong relationship between PSD-95 and Ca V 1.3 labeling with peak values between 0.28 and 0.41 (Fig. 6C) (n ϭ 5). As with Shank, the peak cross-correlation was found near zero displacement and then fell rapidly to baseline within the expected dimensions of a spine. These data suggest that PSD-95, Shank, and Ca V 1.3a subunits are colocalized in medium spiny neurons at excitatory synapses, which are predominantly found on spines.
PSD-95, Shank, and Ca V 1.3a channels appear to be in close physical proximity in medium spiny neurons, but are they bound to one another? To test this possibility, coimmunoprecipitation experiments were performed. Extracts of rat brain synaptosomes were prepared, and protein was immunoprecipitated using an anti-Ca V 1.3a rabbit pAb. A Western blot of this protein was then probed with guinea pig anti-Shank pAb, revealing Shank (Fig.  6 D) . Shank immunoreactivity was lost by preincubation with Ca V 1.3a C-terminal peptide, demonstrating the specificity of the precipitation.
Dialysis with a peptide mime of the Ca V 1.3a PDZ binding domain disrupts the D 2 and M 1 receptor modulation If the interaction between Shank and Ca V 1.3a subunits is critical to the selective modulation by D 2 and M 1 receptors, competitive inhibitors of this binding should disrupt the modulation. Zhang et al. (2005) have shown that Shank1/3 binds to a Ca V 1.3a "ITTL" PDZ motif but does not bind strongly to a Ca V 1.2 "VSNL" PDZ motif. Therefore, peptides containing the ITTL motif should act as efficient competitive inhibitors of the Shank-Ca V 1.3a interaction, whereas peptides containing the VSNL motifs should not. A, Serial dilutions of amplified cDNA from whole-tissue dorsal striatum illustrate that both Ca V 1.3 short (Ca V 1.3b) and long (Ca V 1.3a) forms were present in the dorsal striatum, but Ca V 1.3 long form was detected at a higher frequency. B, Single-cell RT-PCR from a striatal medium spiny neuron shows that Ca V 1.3a mRNA was detected in both ENK-and SP-expressing medium spiny neurons. In dopaminergic neurons, both Ca V 1.3a and Ca V 1.3b mRNA were readily detected (right). C, Serial dilutions of amplified cDNA from whole-tissue dorsal striatum illustrate that Shank1 and Shank3 were detected at higher levels compared with Shank2, as shown by the robust signal. D, Single-cell RT-PCR from a striatal medium spiny neuron shows that Shank1 and Shank3 mRNA were readily detected. E, In a cholinergic interneuron, Shank1 but not Shank3 mRNA was detected.
To provide a functional test of this hypothesis, we turned back to acutely isolated medium spiny neurons in which the modulation of L-type Ca 2ϩ channels could be examined. Although this preparation affords excellent experimental control, the principle regions of excitatory synaptic contact are removed, eliminating much of the structure hypothetically responsible for the selective modulation of Ca V 1.3a channels. To determine whether some of this organization remained after dissociation, neurons were probed with Shank and Ca V 1.3 antibodies. As shown in Figure 7A , despite the dendritic truncation, punctate labeling for Shank and Ca V 1.3a protein was found in the proximal dendrites of dissociated neurons. It is worth noting that D 2 or M 1 receptor agonists failed to modulate L-type currents in neurons lacking any visible dendrite (n Ͼ 20).
Having demonstrated that a portion of the scaffolding remained in the dissociated neurons, peptide mimes of the PDZ binding domains were introduced through the patch pipette during whole-cell recordings. The ability of D 2 receptor agonists to modulate L-type Ca 2ϩ channel currents was unaffected by dialysis with the VSNL peptide but was disrupted by dialysis with an ITTL peptide ( Fig. 7C-E) . The modulation of the step currents, which was mostly attributable to Ca V 2.1/2.2 channel currents, was not significantly altered by either peptide, arguing that the receptor signaling mechanisms were intact [median control suppression, 16% (n ϭ 4); ϩVSNL, 21% (n ϭ 4); ϩITTL, 10% (n ϭ 5); p Ͼ 0.05, Kruskal-Wallis]. Similarly, M 1 receptor modulation of L-type Ca 2ϩ channel currents was not affected by dialysis with the VSNL peptide (Fig. 7 F, H ) (n ϭ 4). In contrast, dialysis with an ITTL peptide dramatically reduced the ability of M 1 receptors to modulate L-type currents (Fig. 7G,H ) (n ϭ 5; p Ͻ 0.05, Mann-Whitney). As with the dopaminergic modulation, the modulation of the currents evoked by the step, which were attributable to primarily the M 4 receptor modulation of Ca V 2.1/2.2 Ca 2ϩ channels, was not significantly affected by the VSNL or ITTL peptides [median control suppression, 19% (n ϭ 5); ϩVSNL, 21% (n ϭ 5); ϩITTL, 10% (n ϭ 5); p Ͼ 0.05, KruskalWallis]. Moreover, neither ITTL (n ϭ 8) nor VSNL (n ϭ 4) peptide had any significant effect on current density or voltage dependence (data not shown) (n ϭ 5; p Ͼ 0.05, Kruskal-Wallis). The failure of the VSNL peptide to alter the D 2 and M 1 receptor modulations of tail currents was not a consequence of its inability to compete for the Ca V 1.2 PDZ domain, because dialysis of the peptide into cortical pyramidal neurons effectively blocked the 5-HT 2 receptor modulation of Ca V 1.2 channel currents (n ϭ 5; control suppression, 26%; ϩVSNL, 10%; p Ͻ 0.05, Kruskal-Wallis) (Day et al., 2002) .
The data presented thus far suggest that the ability of D 2 and M 1 receptors to suppress Ca V 1.3 Ca 2ϩ channel currents depends on channel binding of Shank3/Shank1 proteins. However, why is this interaction important? Our previous studies have shown that the modulation of L-type channels depends on mobilization of Figure 6 . PSD-95, Shank and Ca V 1.3a proteins colocalize in striatal tissue. A, Top row, Confocal images of striatal tissue sections processed for PSD-95 (green) and Shank (red). Overlays of the images revealed a significant level of colocalization that appears yellow. Bottom row, Different striatal section processed for PSD-95 (green) and Ca V 1.3a (red). Both labels have a punctate distribution. Overlaying the images at the right revealed a significant level of colocalization as judged by the appearance of yellow puncta. B, Spatial cross-correlation between PSD-95 and Shank computed from the image shown in the top row of A. The inset is the correlation run out to 6 m showing that the correlation drops to insignificant levels at this distance. The shuffled trace was obtained by randomly shifting the rows and columns of the Shank image and then recomputing the cross-correlation. C, Spatial cross-correlation of PSD-95 and Ca V 1.3a images shown at the bottom of A. Note the strong correlation that rapidly falls within ϳ1.5 m. Again, the shuffled cross-correlation was obtained by randomly shifting the rows and columns of the Ca V 1.3a image and recomputing the correlation. D, Lysates from P2 rat brain synaptosomes were immunoprecipitated with anti-Ca V 1.3a pAb (AM9742) and analyzed by Western blotting with anti-Shank guinea pig pAb (EK1123). The input lane contains one-fiftieth of synaptosomal lysate used for immunoprecipitation experiments. LDC6 peptide (2132-2155 of rat Ca V 1.3a) was added to the immunoprecipitation reactions as indicated at 400 g/ml concentration.
Ca
2ϩ from IP 3 R-controlled intracellular stores (Howe and Surmeier, 1995; Hernandez-Lopez et al., 2000) . Shank may serve to bring Ca V 1.3a channels close to IP 3 Rs and these release sites. One way in which this could be accomplished is through Homer adaptor proteins, which are known to bind to both IP 3 Rs and Shank through Ena/VASP homology 1 (EVH1) domains (Xiao et al., 2000) . If this were the case, medium spiny neurons should express Homer isoforms possessing coiled-coil (CC) regions (Homer 1b-d, Homer 2-3) that allow self-association and assembly of the Shank-Homer-IP 3 R scaffold. Indeed, in agreement with the predictions of in situ hybridization work (Shiraishi et al., 2004) , scRT-PCR profiling of the GABAergic medium spiny neurons (n ϭ 17) revealed expression of Homer 1b/c (16/17), Homer 1d (12/17), and Homer 2 (11/17) but lower levels of the Homer splice variant lacking these domains (Homer1a, 9/17) and Homer 3 (0/ 17) (Fig. 8 A) . To provide a functional test for the involvement of Homer proteins, neurons were dialyzed with a peptide targeting the EVH domain that should competitively inhibit Shank and IP 3 R binding. Doing so suppressed the M 1 receptor modulation of Ca V 1.3 channel currents (n ϭ 6), but dialysis of a similar peptide lacking the EVH binding domain (HBP-KE) failed to alter the modulation (n ϭ 3) (Fig. 8 B) . These data are consistent with the hypothesis that Homer proteins are part of the Shank scaffold necessary for selective modulation of Ca V 1.3 channels. D 2 receptor suppression of Ca V 1.3 Ca 2؉ channel currents dramatically reduce upstate transitions Shank is thought to act as a scaffold at glutamatergic synapses (Sheng, 2001) . In medium spiny neurons, the principal glutamatergic input arises from corticostriatal axons that terminate on dendritic spines (Bolam et al., 2000) . In vivo, convergent activation of this input induces depolarized episodes called upstate, during which neurons can spike (Wilson, 1993) . Recently, an in vitro slice model of these state transitions has been described that utilizes repetitive cortical stimulation or low micromolar concentrations of NMDA that induce tonic firing in corticostriatal pyramidal neurons (Vergara et al., 2003) . In this model, upstates are dependent not only on synaptic input but postsynaptic L-type channels that help create dendritic plateau potentials, maintaining the upstate. Positioning of low-threshold Ca V 1.3a channels at dendritic spines would be one way in which this ACh, acetylcholine; Gp, G-protein; Homer, protein homologous to Ena/vasodilator-stimulated phosphoprotein and WiskottAldrich syndrome protein; Shank, SH3 domain and ankyrin repeat containing protein; CaM, calmodulin; GKAP, guanylate kinase associated protein; PP2B, protein phosphatase 2B/calcineurin (Sheng and Kim, 2000; Xiao et al., 2000) . C, Modulation of tail currents by application of NPA (10 M) in a neuron dialyzed with Ca V 1.2 VSNL peptide for 5 min. D, Tail currents in a wild-type medium spiny neuron after dialysis with the ITTL peptide for 5 min. Note the lack of tail modulation, yet the step current modulation mediated by D 2 receptors was normal. E, Box plot summarizes the results obtained from a sample of seven neurons with the ITTL peptide and four neurons with the VSNL peptide. The difference between the two treatment conditions was statistically significant ( p Ͻ 0.05; Mann-Whitney). F, M 1 receptor modulation of tail currents in a wild-type medium spiny neuron after dialysis with the Ca V 1.2 VSNL peptide for 5 min. The recording conditions are the same as in previous figures except that the muscarinic receptor agonist carbamylcholine chloride (carbachol; 10 M) was used (medium spiny neurons do not express nicotinic receptors; the addition of mecamylamine had no effect on the response). Similar results were obtained with muscarine. G, After dialysis for 5 min with the ITTL peptide, the M 1 receptor modulation of the tail currents is lost, but the M 4 receptor modulation of the step currents is retained. H, Box plot summarizes the results obtained from a sample of five neurons with the ITTL peptide and four neurons with the VSNL peptide. The differences between the two treatment conditions were statistically significant ( p Ͻ 0.05; Mann-Whitney).
glutamatergic receptor driven dendritic electrogenesis could occur. To test for the involvement of Ca V 1.3 channels in this phenomenon, upstates were examined in neurons recorded in slices from wild-type and Ca V 1.3 knock-out mice. Because medium spiny neurons express very low or undetectable levels of Ca V 1.3b mRNA (see above), the deletion of the Ca V 1.3 gene should mimic the selective deletion of Ca V 1.3a subunits. In wild-type neurons, spontaneous upstates were seen in most of the neurons (7 of 10) recorded after bath application of NMDA (5 M) (Fig. 9A) . In contrast, upstates were not seen in neurons from the Ca V 1.3 knock-out under identical recording conditions (n ϭ 5) (Fig.  9B ). This deficit did not appear to arise from an alteration in synaptic function, because local electrical stimulation evoked robust glutamatergic EPSPs, and miniature EPSPs were, if anything, elevated in frequency in Ca V 1.3-deficient neurons (data not shown). Additional evidence that these neurons were otherwise viable came from experiments where bath application of BayK 8644 (1 M) enabled occasional upstate transitions in these neurons (n ϭ 3), presumably by shifting the voltage dependence of the remaining Ca V 1.2 channels into the range of normal Ca V 1.3 channel gating (Bargas et al., 1994) (Fig. 9B, inset) .
To determine whether GPCR suppression of Ca V 1.3 channels could transiently suppress upstate generation, medium spiny neurons were recorded as described above, and the D 2 agonist NPA was applied locally through a puffer pipette. M 1 receptor agonists were not examined because they also modulate K ϩ channels involved in state transitions (W. Shen and Surmeier, unpublished observations). Before NPA application, in the presence of NMDA (5 M), neurons spontaneously oscillated between upstates and downstates, yielding a distinctly bimodal membrane potential distribution (n ϭ 6) (Fig. 9C,D) . In four of six neurons, the application of NPA (10 M) reversibly suppressed the generation of upstates causing the membrane potential distribution to become unimodal (Fig. 9C,D) ; in the other two neurons, NPA had no discernible effect. Although there are undoubtedly other ion channels participating in the state transitions that are potentially targets of modulation, these data are consistent with the hypothesis that modulation of synaptically located Ca V 1.3a channels is an important component of the cellular response to D 2 receptor activation. (Howe and Surmeier, 1995; HernandezLopez et al., 2000) . Although robust, the suppression of L-type Ca 2ϩ currents by these GPCR cascades is invariably incomplete, suggesting that some channels are targeted for modulation and others are not. This differential vulnerability appears to turn in large measure on molecular heterogeneity of the L-type channels themselves. Medium spiny neurons express two major classes of L-type Ca 2ϩ channels: one possessing a pore-forming Ca V 1.2 subunit and the other with a Ca V 1.3 subunit. Four lines of evidence support this conclusion. First, scRT-PCR profiling revealed that both major classes of medium spiny neurons coexpress Ca V 1.2 and Ca V 1.3 subunit mRNAs. Second, L-type Ca 2ϩ channels in medium spiny neurons were heterogeneous in their affinity for dihydropyridines; one component was blocked with high affinity by the dihydropyridine L-type channel antagonist nimodipine (IC 50 , ϳ200 nM), whereas another component was blocked only at higher antagonist concentrations (IC 50 , ϳ2 M). This affinity difference is just what is expected of Ca V 1.2 and Ca V 1.3 channels from work in heterologous expression systems (Safa et al., 2001; Xu and Lipscombe, 2001 ). More compelling perhaps was the loss of the lower affinity component in neurons from Ca V 1.3 knock-out mice and its preservation in Ca V 2.3 knock-outs. Third, as in heterologous expression systems (Xu and Lipscombe, 2001) , Ca 2ϩ channels with a low dihydropyridine affinity (Ca V 1.3) opened at more negative membrane potentials than did high affinity Ca V 1.2 channels. Nominal Ca V 1.3 channel half-activation voltages were 10 -15 mV more negative than those for Ca V 1.2 channels. Fourth, immunocytochemical analysis revealed the presence of Ca V 1.3 protein in medium spiny neurons, complementing previous work showing Ca V 1.2 expression (Hell et al., 1993b) .
Discussion
Three lines of evidence argue that D 2 and M 1 receptor signaling cascades differentially regulate these two channel types. The first comes from the failure of either GPCR to modulate BayK 8644 tail currents in neurons where functional Ca V 1.3 subunits had been genetically deleted. The second comes from the ability of high, but not low, Ca V 1.2-selective concentrations of dihydropyridine antagonists to occlude the modulation. The third comes from the similarity in gating voltage dependence of the modulated channels and Ca V 1.3 Ca 2ϩ channels.
The selective modulation appears to be dependent on Shank3/ Shank1 binding to Ca V 1.3a subunits One way in which this kind of signaling specificity could be achieved is by bringing the receptors, channels, and signaling elements to the same subcellular locale. The best-characterized signaling complex of this sort is the postsynaptic density at glutamatergic synapses, where scaffolding or anchoring proteins organize and concentrate transduction proteins (Kennedy, 1998; Sheng and Kim, 2000) . Shank has been referred to as a "master" Figure 8 . Homer mRNA is expressed in medium spiny neurons, and binding of Homer is necessary for M 1 muscarinic receptor modulation of Ca V 1.3 L-type calcium channels. A, Singlecell RT-PCR from a striatal medium spiny neuron shows that Homer 1b/c and Homer 2 are readily detected in both ENK-and SP-expressing medium spiny neurons. B, Carbachol application (10 l) had no effect on L-current in medium spiny neurons dialyzed with Homer binding protein (HBP) (median, 0%; n ϭ 6). In medium spiny neurons dialyzed with HBP-KE control peptide, L-current was inhibited by carbachol (median, 16%; n ϭ 3; p Ͻ 0.05, Mann-Whitney). Also shown is the muscarine inhibition of medium spiny neurons from wild-type mice (median, 20%; n ϭ 5). There is no difference between the control group of neurons without peptide dialysis and the group of neurons dialyzed with HBP-KE ( p Ͼ 0.05; Mann-Whitney). The asterisk is an "outlier," a point that is Ͼ1.5 times the interquartile range beyond the interquartiles in the box plot (Tukey, 1977; Song et al., 2000) .
ences, it is tempting to speculate that coexpression of Ca V 1.2 and Ca V 1.3 channels enables neurons to sense and signal over a much broader activity range than would be possible with either channel alone.
GPCR-Shank-Ca V 1.3 channel complex regulates glutamatergic receptor driven upstates in medium spiny neurons The recruitment of Ca V 1.3 channels to synaptic signaling complexes by Shank proteins provides a framework in which we can begin to understand activity-dependent plasticity in medium spiny neurons. In vivo, glutamatergic synaptic input promotes the transition from a hyperpolarized downstate to a depolarized upstate (Wilson, 1993) . Although the upstate transitions depend on glutamatergic receptors for their initiation, postsynaptic voltage-dependent ion channels clearly shape their duration and potential envelope. L-type channels appear to be particularly important in this phenomena, because dihydropyridine antagonists suppress upstate transitions and agonists promote them (Vergara et al., 2003) . Our data extend these findings by showing the loss of upstate transitions in neurons from Ca V 1.3 knock-out mice or in neurons after activation of GPCRs that suppress Ca V 1.3 channel currents. This disruption suggests that there is a synergy between glutamatergic receptors and Ca V 1.3 channels in the generation of upstates that is regulated by D 2 dopaminergic receptors. The strategic positioning of Ca V 1.3 channels afforded by Shank also may be a critical factor in determining how afferent synaptic activity is translated into long-term alterations in neuronal function. For example, in striatal neurons, long-term synaptic depression (LTD) is dependent on opening of L-type Ca 2ϩ channels (Calabresi et al., 1994) . Synaptic scaffolding of Ca V 1.3 channels may be critical to LTD induction. Activity-dependent alterations in the phosphorylation state of transcription factors that signal synaptic events to the nucleus may also be depend on "privileged positioning" of L-type Ca 2ϩ channels (Cepeda et al., 1998; Rajadhyaksha et al., 1999; Zhang et al., 2005) . The inclusion of D 2 and M 1 GPCRs in this synaptic complex creates a mechanism by which the two most clinically important striatal modulators (dopamine and acetylcholine) could regulate this plasticity.
